Ticker
KALVCompany Name
KALVISTA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 124.3M | 3.24 | $ 38.38M |
3/31/2025 | $ 131.62M | 2.91 | $ 45.17M |
12/31/2024 | $ 167.29M | 6.53 | $ 25.61M |
9/30/2024 | $ 41.58M | 1.88 | $ 22.16M |
6/30/2024 | $ 31.85M | 1.42 | $ 22.41M |
3/31/2024 | $ 31.79M | 1.39 | $ 22.81M |
12/31/2023 | $ 23.06M | 1.21 | $ 19.13M |
9/30/2023 | $ 57.67M | 3.25 | $ 17.75M |
6/30/2023 | $ 49.41M | 3.5 | $ 14.13M |
3/31/2023 | $ 56.24M | 3.74 | $ 15.03M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for KALVISTA PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 16.17M ] / LiabilitesC [ $ 9.54M ]
(=) Cash Ratio [ 1.7 ]
Minimum
Dec 31, 2023
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |